AI Article Synopsis
- Organometallic complexes are gaining interest as potential anticancer therapies, especially to address the limitations of existing platinum-based drugs.
- Researchers synthesized and characterized four new cobalt(III)-cyclopentadienyl complexes using various analytical techniques.
- These complexes exhibited significant cytotoxic effects in multiple human cancer cell lines through mechanisms like ROS production and apoptosis, while proving nontoxic to healthy cells in an ex ovo chick embryo model.
Article Abstract
In recent years, organometallic complexes have attracted much attention as anticancer therapeutics aiming at overcoming the limitations of platinum drugs that are currently marketed. Still, the development of half-sandwich organometallic cobalt complexes remains scarcely explored. Four new cobalt(III)-cyclopentadienyl complexes containing N,N-heteroaromatic bidentate, and phosphane ligands were synthesized and fully characterized by elemental analysis, spectroscopic techniques, and DFT methods. The cytotoxicity of all complexes was determined in vitro by the MTS assay in colorectal (HCT116), ovarian (A2780), and breast (MDA-MB-231 and MCF-7) human cancer cell lines and in a healthy human cell line (fibroblasts). The complexes showed high cytotoxicity in cancer cell lines, mostly due to ROS production, apoptosis, autophagy induction, and disruption of the mitochondrial membrane. Also, these complexes were shown to be nontoxic in vivo in an ex ovo chick embryo yolk sac membrane (YSM) assay.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10988555 | PMC |
| http://dx.doi.org/10.1021/acs.inorgchem.3c03696 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!